Back diagnosis stalls Méthalie’s Sunderland move, sparks transfer dispute

An ominous back diagnosis has turned Dayann Méthalie’s £20‑million Sunderland offer into a dispute, while the English club now pulls the original proposal amid medical concerns. The 20‑year‑old left‑back from FC Toulouse, who impressed in Ligue 1, now faces a stalled transfer as both clubs grapple with health reports and financial expectations.

Original offer and medical alarm

Sunderland originally pledged a “overly high‑priced” offer, a figure that featured prominently in the news, transfers and Gerüchte surrounding the deal. The club’s medical check revealed a back injury that could have serious consequences, prompting the English side to reconsider the agreed basis fee of €28 million.

Market value and comparable sales

FC Toulouse valued Méthalie at €18 million and hoped to exceed the record set by the recent sale of striker Emersonn, a 22‑year‑old Brazilian sold to Ipswich Town for a similar amount. The market‑wert analysis suggested that Méthalie could command up to €33 million with bonuses, while Emersonn’s deal could reach €32 million.

In the wake of the diagnosis, Sunderland shifted from the original offer to a new proposal that the French side deemed insufficient. The club now favours a loan with a purchase option, a structure that the Toulouse management rejects as it would not meet their financial needs.

Medical opinions diverge: Toulouse’s medical department downplays the injury, stating the player’s fitness is not jeopardised, while a back specialist based in Paris also sees no problem. Sunderland, however, argues that the risk of a prolonged absence could force them to forgo the player for six weeks.

The French club is under pressure to secure transfer revenue to balance its year‑end accounts, making the stalled deal particularly painful. Unverständnis in Toulouse grew when Sunderland arrived with entirely new transfer modalities despite the earlier basis‑ablöse agreement.

This contrast between Sunderland’s cautious financial recalibration and Toulouse’s urgent revenue drive highlights how a single medical report can transform a high‑profile transfer into a protracted dispute, leaving the player’s future uncertain.